Loading…
Lobbying Spend
—
Filings
56
Firms Hired
1
Active Period
2004–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Support for H.R. 1672 - Maintaining Investments in New Innovation Act Issues related to access and coverage in Medicare program. Implementation of provisions included in Subtitle B of PL. 117-169-Infation Reduction Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1672
Support for H.R. 1672 - Maintaining Investments in New Innovation Act Issues related to access and coverage in Medicare program. Implementation of provisions included in Subtitle B of PL. 117-169-Infation Reduction Act of 2022
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Support for H.R. 1672 - Maintaining Investments in New Innovation Act Issues related to access and coverage in Medicare program. Implementation of provisions included in Subtitle B of PL. 117-169-Infation Reduction Act of 2022
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.10445
Joe Fiandra Access to Home Infusion Act of 2023
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5397
Maintaining Investments in New Innovation Act
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5547
Maintaining Investments in New Innovation Act
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S.476
Joe Fiandra Access to Home Infusion Act of 2023
2024 · third_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan), and H.R. 7623 - Telehealth Modernization Act of 2024 Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5397
Maintaining Investments in New Innovation Act
2024 · third_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan), and H.R. 7623 - Telehealth Modernization Act of 2024 Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5547
Telehealth Modernization Act of 2024
2024 · third_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan), and H.R. 7623 - Telehealth Modernization Act of 2024 Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7623
American Medical Innovation and Investment Act of 2024
2024 · third_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan), and H.R. 7623 - Telehealth Modernization Act of 2024 Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.8816
Maintaining Investments in New Innovation Act
2024 · third_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan), and H.R. 7623 - Telehealth Modernization Act of 2024 Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S.476
Joe Fiandra Access to Home Infusion Act of 2023
2024 · second_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5397
Maintaining Investments in New Innovation Act
2024 · second_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5547
American Medical Innovation and Investment Act of 2024
2024 · second_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.8816
Maintaining Investments in New Innovation Act
2024 · second_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Provisions related to home infusion in H.R.8816 - American Medical Innovation and Investment Act of 2024 (Rep. Buchanan) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S.476
Joe Fiandra Access to Home Infusion Act of 2023
2024 · first_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539, S.3131 - ORPHAN Cures Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5397
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539, S.3131 - ORPHAN Cures Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5539
Maintaining Investments in New Innovation Act
2024 · first_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539, S.3131 - ORPHAN Cures Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5547
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539, S.3131 - ORPHAN Cures Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S.3131
Maintaining Investments in New Innovation Act
2024 · first_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539, S.3131 - ORPHAN Cures Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S.476
Protecting Patients Against PBM Abuses Act
2023 · fourth_quarter · Firm: THE MCMANUS GROUP
Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539 - ORPHAN Cures Act H.R.2880 - Protecting Patients Against PBM Abuses Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2880
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3281 - The Transparent PRICE Act, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3281
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3281 - The Transparent PRICE Act, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4507
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: THE MCMANUS GROUP
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3281 - The Transparent PRICE Act, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5378
Source: Senate LDA